Total Payments
$7,455
2024 Payments
$404.74
Companies
9
Transactions
42
Medicare Patients
3,495
Medicare Billing
$662,213
Payment Breakdown by Category
Other$3,573 (47.9%)
Food & Beverage$2,473 (33.2%)
Travel$1,410 (18.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $3,573 | 5 | 47.9% |
| Food and Beverage | $2,473 | 33 | 33.2% |
| Travel and Lodging | $1,410 | 4 | 18.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Fidia Pharma USA Inc. | $3,523 | 4 | $0 (2017) |
| Stratus Medical, LLC | $3,129 | 19 | $0 (2024) |
| DePuy Synthes Sales Inc. | $230.51 | 10 | $0 (2019) |
| Allergan, Inc. | $206.10 | 2 | $0 (2020) |
| BOSTON SCIENTIFIC CORPORATION | $113.30 | 2 | $0 (2021) |
| Avanos Medical | $111.06 | 1 | $0 (2019) |
| Flexion Therapeutics, Inc. | $70.91 | 2 | $0 (2019) |
| Medtronic USA, Inc. | $37.47 | 1 | $0 (2017) |
| Nevro Corp. | $34.42 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $404.74 | 3 | Stratus Medical, LLC ($404.74) |
| 2023 | $1,956 | 11 | Stratus Medical, LLC ($1,956) |
| 2022 | $767.97 | 5 | Stratus Medical, LLC ($767.97) |
| 2021 | $113.30 | 2 | BOSTON SCIENTIFIC CORPORATION ($113.30) |
| 2020 | $107.63 | 1 | Allergan, Inc. ($107.63) |
| 2019 | $198.66 | 4 | Avanos Medical ($111.06) |
| 2018 | $71.60 | 3 | DePuy Synthes Sales Inc. ($50.69) |
| 2017 | $3,836 | 13 | Fidia Pharma USA Inc. ($3,523) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/27/2024 | Stratus Medical, LLC | Nimbus (Device) | Food and Beverage | Cash or cash equivalent | $151.81 | General |
| Category: Neuro & Physical Medical Device | ||||||
| 02/17/2024 | Stratus Medical, LLC | Nimbus (Device) | Food and Beverage | Cash or cash equivalent | $107.89 | General |
| Category: Neuro & Physical Medical Device | ||||||
| 02/06/2024 | Stratus Medical, LLC | Nimbus (Device) | Food and Beverage | Cash or cash equivalent | $145.04 | General |
| Category: Neuro & Physical Medical Device | ||||||
| 11/17/2023 | Stratus Medical, LLC | Nimbus (Device) | Food and Beverage | Cash or cash equivalent | $153.54 | General |
| Category: Neuro & Physical Medical Device | ||||||
| 06/01/2023 | Stratus Medical, LLC | Nimbus (Device) | Travel and Lodging | Cash or cash equivalent | $589.58 | General |
| Category: Neuro & Physical Medical Device | ||||||
| 06/01/2023 | Stratus Medical, LLC | Nimbus (Device) | Food and Beverage | Cash or cash equivalent | $206.92 | General |
| Category: Neuro & Physical Medical Device | ||||||
| 06/01/2023 | Stratus Medical, LLC | Nimbus (Device) | Travel and Lodging | Cash or cash equivalent | $49.50 | General |
| Category: Neuro & Physical Medical Device | ||||||
| 06/01/2023 | Stratus Medical, LLC | Nimbus (Device) | Food and Beverage | Cash or cash equivalent | $37.57 | General |
| Category: Neuro & Physical Medical Device | ||||||
| 06/01/2023 | Stratus Medical, LLC | Nimbus (Device) | Travel and Lodging | Cash or cash equivalent | $35.00 | General |
| Category: Neuro & Physical Medical Device | ||||||
| 06/01/2023 | Stratus Medical, LLC | Nimbus (Device) | Food and Beverage | Cash or cash equivalent | $19.58 | General |
| Category: Neuro & Physical Medical Device | ||||||
| 06/01/2023 | Stratus Medical, LLC | Nimbus (Device) | Food and Beverage | Cash or cash equivalent | $17.15 | General |
| Category: Neuro & Physical Medical Device | ||||||
| 06/01/2023 | Stratus Medical, LLC | Nimbus (Device) | Food and Beverage | Cash or cash equivalent | $14.30 | General |
| Category: Neuro & Physical Medical Device | ||||||
| 03/22/2023 | Stratus Medical, LLC | Nimbus (Device) | Food and Beverage | Cash or cash equivalent | $97.20 | General |
| Category: Neuro & Physical Medical Device | ||||||
| 03/01/2023 | Stratus Medical, LLC | Nimbus (Device) | Travel and Lodging | Cash or cash equivalent | $735.55 | General |
| Category: Neuro & Physical Medical Device | ||||||
| 12/14/2022 | Stratus Medical, LLC | Nimbus (Device) | Food and Beverage | Cash or cash equivalent | $307.38 | General |
| Category: Neuro & Physical Medical Device | ||||||
| 08/25/2022 | Stratus Medical, LLC | Nimbus (Device) | Food and Beverage | Cash or cash equivalent | $14.41 | General |
| Category: Neuro & Physical Medical Device | ||||||
| 08/24/2022 | Stratus Medical, LLC | Nimbus (Device) | Food and Beverage | Cash or cash equivalent | $148.98 | General |
| Category: Neuro & Physical Medical Device | ||||||
| 08/24/2022 | Stratus Medical, LLC | Nimbus (Device) | Food and Beverage | Cash or cash equivalent | $23.61 | General |
| Category: Neuro & Physical Medical Device | ||||||
| 04/14/2022 | Stratus Medical, LLC | Nimbus (Device) | Food and Beverage | Cash or cash equivalent | $273.59 | General |
| Category: Neuro & Physical Medical Device | ||||||
| 07/22/2021 | BOSTON SCIENTIFIC CORPORATION | SPECTRA WAVEWRITER (Device) | Food and Beverage | In-kind items and services | $97.92 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/19/2021 | BOSTON SCIENTIFIC CORPORATION | SPECTRA WAVEWRITER (Device) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: PAIN MANAGEMENT | ||||||
| 03/06/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $107.63 | General |
| Category: HYPERHYDROSIS | ||||||
| 08/14/2019 | Avanos Medical | GENERATOR (Device) | Food and Beverage | In-kind items and services | $111.06 | General |
| Category: PAIN MANAGEMENT | ||||||
| 03/08/2019 | DePuy Synthes Sales Inc. | ORTHOVISC (Device) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Sports Early Intervention | ||||||
| 02/06/2019 | DePuy Synthes Sales Inc. | ORTHOVISC (Device) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Sports Early Intervention | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 901 | 2,558 | $1.6M | $166,878 |
| 2022 | 20 | 988 | 1,741 | $1.9M | $174,121 |
| 2021 | 19 | 965 | 1,560 | $1.6M | $184,635 |
| 2020 | 16 | 641 | 1,941 | $983,067 | $136,579 |
Total Patients
3,495
Total Services
7,800
Medicare Billing
$662,213
Procedure Codes
72
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 229 | 404 | $202,000 | $45,655 | 22.6% |
| J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | Office | 2023 | 34 | 58 | $127,078 | $32,081 | 25.2% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 98 | 182 | $229,955 | $18,343 | 8.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 115 | 116 | $89,900 | $16,746 | 18.6% |
| J7322 | Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | Office | 2023 | 12 | 984 | $43,296 | $13,014 | 30.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 90 | 111 | $41,625 | $8,602 | 20.7% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 52 | 61 | $217,845 | $6,845 | 3.1% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 25 | 25 | $127,145 | $5,087 | 4.0% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 28 | 48 | $155,375 | $4,633 | 3.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 22 | $15,400 | $3,262 | 21.2% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 27 | 38 | $104,500 | $3,168 | 3.0% |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | Office | 2023 | 11 | 46 | $14,950 | $2,736 | 18.3% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 26 | 45 | $87,450 | $2,437 | 2.8% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 31 | 37 | $59,570 | $1,667 | 2.8% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 22 | 22 | $46,920 | $1,348 | 2.9% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 14 | 19 | $21,660 | $964.38 | 4.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 67 | 340 | $3,849 | $291.81 | 7.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 232 | 399 | $199,500 | $44,983 | 22.5% |
| J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | Office | 2022 | 34 | 59 | $129,269 | $35,273 | 27.3% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 92 | 181 | $232,215 | $19,089 | 8.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 111 | 111 | $86,025 | $16,094 | 18.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 116 | 146 | $54,750 | $11,480 | 21.0% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2022 | 49 | 62 | $219,390 | $6,955 | 3.2% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2022 | 31 | 36 | $168,090 | $6,820 | 4.1% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2022 | 31 | 53 | $177,375 | $5,183 | 2.9% |
About Dr. Jonathan Kirschner, MD
Dr. Jonathan Kirschner, MD is a Electrodiagnostic Medicine healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2008. The National Provider Identifier (NPI) number assigned to this provider is 1699937722.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Kirschner, MD has received a total of $7,455 in payments from pharmaceutical and medical device companies, with $404.74 received in 2024. These payments were reported across 42 transactions from 9 companies. The most common payment nature is "Honoraria" ($3,573).
As a Medicare-enrolled provider, Kirschner has provided services to 3,495 Medicare beneficiaries, totaling 7,800 services with total Medicare billing of $662,213. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Ad
Practice Information
- Specialty Electrodiagnostic Medicine
- Other Specialties Sports Medicine, Interventional Pain Medicine
- Location New York, NY
- Active Since 06/30/2008
- Last Updated 04/23/2021
- Taxonomy Code 204R00000X
- Entity Type Individual
- NPI Number 1699937722
Products in Payments
- Hymovis (Device) $3,523
- Nimbus (Device) $3,129
- ORTHOVISC (Device) $230.51
- SPECTRA WAVEWRITER (Device) $113.30
- GENERATOR (Device) $111.06
- BOTOX (Biological) $107.63
- BOTOX THERAPEUTIC (Biological) $98.47
- Zilretta (Drug) $70.91
- RESTORE (Device) $37.47
- Senza Spinal Cord Stimulation System (Device) $34.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.